6Stein G, Busch M, Muller A, et al. Are advanced glycation end products cardiovascular risk factors in patients with CRF? Am J Kidney Dis,2003,41 (3 Suppl 1 ) :S52-S56.
7London GM. Left ventricular hypertrophy: why does it happen?Nephrol Dial Transplant,2003,18 Suppl 8 :viii2- viii6.
8Heyman SN, Rosenberger C, Rosen S. Erythropoietin : a potential remedy for renal tubular injury7. Kidney Int,2004,65:737-738.
9Foley RN, Parfrey PS, Morgan J, et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int,2000,58 : 1325-1335.
10Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease.Am J Kidney Dis, 1996,28:53-61.
1Banu Akta? Y?lmaz,Mustafa Altay,Ceyla Konca De?ertekin,Ali R?za ?imen,?zlem Turhan ?yidir,Aydan Biri,Osman Yüksel,Füsun Balo? T?rüner,Metin Arslan.??Hyperparathyroid crisis presenting with hyperemesis gravidarum(J)Archives of Gynecology and Obstetrics . 2014 (4)
2Bano Gul,Mansour Sahar,Nussey Stephen.The association of primary hyperparathyroidism and primary ovarian failure: a de novo t(X; 2) (q22p13) reciprocal translocation. European journal of endocrinology / European Federation of Endocrine Societies . 2008
